ENTERO — Entero Healthcare Solutions Income Statement
0.000.00%
- IN₹56.71bn
- IN₹56.33bn
- IN₹50.96bn
- 43
- 26
- 66
- 40
Annual income statement for Entero Healthcare Solutions, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 17,797 | 25,221 | 33,002 | 39,223 | 50,958 |
Cost of Revenue | |||||
Gross Profit | 1,382 | 2,056 | 2,641 | 3,464 | 4,863 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17,745 | 25,174 | 32,604 | 38,355 | 49,549 |
Operating Profit | 52.7 | 46.8 | 398 | 868 | 1,409 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -108 | -198 | -36.9 | 356 | 1,387 |
Provision for Income Taxes | |||||
Net Income After Taxes | -154 | -294 | -111 | 398 | 1,074 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -155 | -299 | -116 | 391 | 948 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -155 | -299 | -116 | 391 | 948 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.57 | -6.88 | -2.66 | 10.8 | 21.8 |
Dividends per Share |